An animal experiment also identified the potential role of GB1 in the treatment of NAFLD, as it could decrease the blood glucose level induced by STZ in rabbits and was protective of the liver [15]. The gene discussed is GABBR1; the disease is metabolic dysfunction-associated steatotic liver disease.